Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KO US Equity

Coca Cola CoConsumer Staples · Beverages · CIK 21344 · FY ends Dec 31
$88.82
+1.84 (+2.12%)
USD · as of 2026-08-18 · marketstack
2 registered studies · 0 active

Studies where KO is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

2 interventional

Held by 29 tracked-famous managers (Berkshire Hathaway Inc, MARSHALL WACE, LLP, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Balyasny Asset Management L.P., +24 more) · FINRA short interest 2.4 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 10 sells · government filings 180d: 2 congress / 5 executive

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
Effects of Low Calorie Sweeteners on Dietary Intakes, Hunger, Appetite and SatietyNCT02297880Subjective sensations: hunger, satiety and desire to eatRandomized · Open-label · OtherNot applicableCompletedOther: Beverage containing low calorie sweeteners, Still waterEating Behavior170Mar 2016actual2017-02-09
Evaluation of a New Orange-Based Beverage Enriched With Polyphenols in Adult HumansNCT01290250Systolic blood pressureRandomized · Quadruple-masked · Basic scienceNot applicableCompletedOther: Orange juice based beverage enriched in polyphenolsOverweight, Obesity210Jan 2011actual2013-03-15

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19